Boston Scientific announced on social media that it completed its previously announced acquisition of Bolt Medical. News of the acquisition’s closing comes just days after the FDA granted 510(k) clearance for the Bolt IVL system on March 25, about two months post-submission (Jan. 27). The company wrote on LinkedIn: “We have successfully closed the acquisition of Bolt Medical. We look forward to advancing the intravascular lithotripsy (IVL) therapy developed by Bolt which will complement our cardiovascular portfolio by expanding treatment options for coronary and peripheral disease.”
Read the full article: Boston Scientific Closes Bolt Medical Acquisition //
Source: https://www.massdevice.com/boston-scientific-closes-bolt-medical-acquisition/